| Literature DB >> 29999552 |
Yingru Zhi1, Hao Zhou2, Abudoureyimu Mubalake1, Ying Chen1, Bei Zhang2, Kai Zhang1, Xiaoyuan Chu1, Rui Wang1.
Abstract
MicroRNAs are small non-coding RNAs that play critical roles in the regulatory mechanisms involving cell differentiation, proliferation, apoptosis and tumorigenesis. Recent research efforts have been conducted to apply these discoveries into clinical functions, including the early diagnosis and therapeutic outcome of patients with cancer. Previous studies have shown that microRNA-149 (miR-149) is dysregulated in various human cancers and exerts its effects on tumorigenesis and tumour progression. In this review, we summarized the potential roles of miR-149 dysregulation and its target genes during tumorigenesis and clinical treatment of human cancers.Entities:
Keywords: cancer; chemotherapy; diagnosis; dysregulation; miR-149; prognosis
Mesh:
Substances:
Year: 2018 PMID: 29999552 PMCID: PMC6528861 DOI: 10.1111/cpr.12465
Source DB: PubMed Journal: Cell Prolif ISSN: 0960-7722 Impact factor: 6.831